A
Anna Pluzhnikov
Researcher at University of Chicago
Publications - 29
Citations - 3873
Anna Pluzhnikov is an academic researcher from University of Chicago. The author has contributed to research in topics: Population & Genome-wide association study. The author has an hindex of 22, co-authored 29 publications receiving 3632 citations. Previous affiliations of Anna Pluzhnikov include University of Illinois at Chicago.
Papers
More filters
Journal ArticleDOI
A genome-wide search for asthma susceptibility loci in ethnically diverse populations
David G. Marsh,Nancy E. Maestri,Linda R. Freidhoff,Kathleen C. Barnes,Alkis Togias,Eva Ehrlich,Terri H. Beaty,David L. Duffy,Richard R. Rosenthal,Farhad Imani,Georgia M. Dunston,Paulette Furbert-Harris,Floyd J. Malveaux,Carole Ober,Nancy J. Cox,Lucille A. Lester,Rhonda Peterson,Heidi Gidley,Anna Pluzhnikov,Jennifer L. Anderson,Julian Solway,Alan R. Leff,Raoul L. Wolf,Mark Wylam,Bradley Kurtz,Anthony Richardson,Rodney Parry,Malcolm N. Blumenthal,Richard A. King,William S. Oetting,Delores Drury,Andreas Rosenberg,Lisa R. Daniels,Charlene McEvoy,Jay Lou,Mark Hamra,Marcia J. Brott,Stephen S. Rich,Beverly J. Spray,James L. Weber,Bo Yuan,Zhenyuan Wang,Eugene R. Bleecker,PJ Amelung,Betsy Rechstiner,Deborah A. Meyers,Jonathan M. Samet,Denise Wiesch,Jianfeng Xu,Shirley Murphy,Susan Banks-Schlegel +50 more
TL;DR: A genome-wide search in 140 families with ≥2 asthmatic sibs, from three racial groups and report evidence for linkage to six novel regions, including 5p15 (P= 0.0008) and 17p11.1–q11.2 (/> = 0.0015) in African Americans and 11p15 and 19q13 (P =0.0013) in Caucasians and Hispanics.
Journal ArticleDOI
Insulin gene mutations as a cause of permanent neonatal diabetes
Julie Støy,Emma L. Edghill,Sarah E. Flanagan,Honggang Ye,Veronica Paz,Anna Pluzhnikov,Jennifer E. Below,M. Geoffrey Hayes,Nancy J. Cox,Gregory M. Lipkind,Rebecca B. Lipton,Siri Atma W. Greeley,Ann-Marie Patch,Sian Ellard,Donald F. Steiner,Andrew T. Hattersley,Louis H. Philipson,Graeme I. Bell +17 more
TL;DR: Ten heterozygous mutations in the human insulin gene are reported in 16 probands with neonatal diabetes, and it is predicted that they prevent normal folding and progression of proinsulin in the insulin secretory pathway.
Journal ArticleDOI
Rational inferences about departures from hardy-weinberg equilibrium
TL;DR: Results suggest that significant DHW can be expected in relatively small samples of patients over a range of genetic models, and propose a goodness-of-fit test to aid investigators in determining whether a DHW observed in the context of a case-control study is consistent with a genetic disease model.
Journal ArticleDOI
Genome-wide association study of obsessive-compulsive disorder.
S. E. Stewart,Dongmei Yu,Jeremiah M. Scharf,Benjamin M. Neale,Jesen Fagerness,Carol A. Mathews,Paul D. Arnold,Patrick Evans,Eric R. Gamazon,Lisa Osiecki,Lauren M. McGrath,Stephen A. Haddad,Jacquelyn Crane,Dianne M. Hezel,C. Illman,C. Mayerfeld,Anuar Konkashbaev,Chunyu Liu,Anna Pluzhnikov,Anna Tikhomirov,Christopher K. Edlund,Scott L. Rauch,Rainald Moessner,Peter Falkai,W. Maier,Stephan Ruhrmann,Hans-Jörgen Grabe,Leonhard Lennertz,Michael Wagner,Laura Bellodi,Maria Cristina Cavallini,Margaret A. Richter,Edwin H. Cook,James L. Kennedy,D. Rosenberg,Dan J. Stein,Sian M. J. Hemmings,Christine Lochner,Amin Azzam,Denise A. Chavira,Eduardo Fournier,Helena Garrido,Brooke Sheppard,Paula Umaña,D. L. Murphy,Jens R. Wendland,Jeremy Veenstra-VanderWeele,Damiaan Denys,Rianne M. Blom,Dieter Deforce,F. Van Nieuwerburgh,H.G.M. Westenberg,Susanne Walitza,Karin Egberts,Tobias J. Renner,Euripedes Constantino Miguel,Carolina Cappi,Ana Gabriela Hounie,M Conceição do Rosário,Aline S. Sampaio,Homero Vallada,Humberto Nicolini,Nuria Lanzagorta,Beatriz Camarena,Richard Delorme,Marion Leboyer,Carlos N. Pato,Michele T. Pato,E. Voyiaziakis,Peter Heutink,Danielle C. Cath,Danielle Posthuma,J.H. Smit,Jack Samuels,Oscar J. Bienvenu,Bernadette Cullen,Abby J. Fyer,Marco A. Grados,Benjamin D. Greenberg,James T. McCracken,Mark A. Riddle,Youfa Wang,Vladimir Coric,James F. Leckman,Michael H. Bloch,Christopher Pittenger,Valsamma Eapen,Donald W. Black,Roel A. Ophoff,Eric Strengman,Daniele Cusi,Maurizio Turiel,Francesca Frau,Fabio Macciardi,J. R. Gibbs,Mark R. Cookson,Andrew B. Singleton,S. Arepalli,Allissa Dillman,L. Ferrucci,D. G. Hernandez,R. Johnson,Dan L. Longo,M. A. Nalls,Richard O'Brien,Bryan J. Traynor,Juan C. Troncoso,M. Van Der Brug,H. R. Zielke,Alan B. Zonderman,John Hardy,Andrew Crenshaw,Melissa Parkin,Daniel B. Mirel,David V. Conti,Shaun Purcell,Gerald Nestadt,Gregory L. Hanna,Michael A. Jenike,James A. Knowles,Nancy J. Cox,David L. Pauls,John Hardy,Mina Ryten,Colin Smith,Daniah Trabzuni,Robert Walker,Michael E. Weale +127 more
TL;DR: Although no SNPs were identified to be associated with OCD at a genome-wide significant level in the combined trio–case–control sample, a significant enrichment of methylation QTLs and frontal lobe expression quantitative trait loci (eQTLs) was observed within the top-ranked SNPs, suggesting these top signals may have a broad role in gene expression in the brain, and possibly in the etiology of OCD.
Journal ArticleDOI
Genetic variants associated with warfarin dose in African- American individuals: a genome-wide association study
Minoli A. Perera,Larisa H. Cavallari,Nita A. Limdi,Eric R. Gamazon,Anuar Konkashbaev,Roxana Daneshjou,Anna Pluzhnikov,Dana C. Crawford,Jelai Wang,Nianjun Liu,Nicholas P. Tatonetti,Stephane Bourgeois,Harumi Takahashi,Yukiko Bradford,Benjamin Burkley,Robert J. Desnick,Jonathan L. Halperin,Sherief Khalifa,Taimour Y. Langaee,Steven A. Lubitz,Edith A. Nutescu,Matthew T. Oetjens,Mohamed H. Shahin,Shitalben R. Patel,Hersh Sagreiya,Matthew Tector,Karen E. Weck,Mark J. Rieder,Stuart A. Scott,Alan H.B. Wu,James K. Burmester,Mia Wadelius,Panos Deloukas,Michael J. Wagner,Taisei Mushiroda,Michiaki Kubo,Dan M. Roden,Nancy J. Cox,Russ B. Altman,Teri E. Klein,Yusuke Nakamura,Julie A. Johnson +41 more
TL;DR: A novel CYP2C single nucleotide polymorphism exerts a clinically relevant effect on warfarin dose in African Americans, independent of CYP 2C9*2 and CYP9*3, and incorporation of this variant into pharmacogenetic dosing algorithms could improve warFarin dose prediction in this population.